Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $25.64M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −53.9% to +107.0% across the middle 80 percent of the group, with a median of −27.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PRPO | Precipio, Inc. | $30.85 | +34.60% | +29.51% | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $10.88 | +0.51% | +4.97% | +6.62% |
| ABDX.L | Abingdon Health Plc | 11.00 GBP | +11.68% | +71.87% | +100.00% |
| RENX.L | Renalytix Plc | 4.25 GBP | +60.38% | −27.97% | −27.35% |
| GSS.AX | Genetic Signatures Limited | 0.08 AUD | +38.33% | −66.12% | −72.33% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| BIAF | bioAffinity Technologies, Inc. | $5.19 | +661.00% | +325.41% | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.